Atinum Investment Co., Ltd (KOSDAQ:021080)
2,020.00
-150.00 (-6.91%)
At close: Jul 28, 2026
Atinum Investment Revenue
Atinum Investment had revenue of 3.46B KRW in the quarter ending September 30, 2013, with 193.07% growth. This brings the company's revenue in the last twelve months to 8.92B, up 7.48% year-over-year. In the year 2012, Atinum Investment had annual revenue of 5.67B, down -42.95%.
Revenue (ttm)
8.92B
Revenue Growth
+7.48%
P/S Ratio
10.64
Revenue / Employee
524.67M
Employees
17
Market Cap
94.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 5.67B | -4.27B | -42.95% |
| Dec 31, 2011 | 9.94B | 3.50B | 54.40% |
| Dec 31, 2010 | 6.44B | -225.00M | -3.38% |
| Dec 31, 2009 | 6.66B | -61.43B | -90.22% |
| Dec 31, 2008 | 68.09B | -3.39B | -4.74% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sambo Motors | 1.70T |
| Se Gyung Hi Tech | 285.00B |
| DongKoo Bio & Pharma | 242.08B |
| HYUNDAI BIOLAND | 135.04B |
| Rorze Systems | 134.68B |
| Chemtros | 61.95B |
| NOVATECH | 49.63B |
| EXEM Co., Ltd. | 49.25B |
Atinum Investment News
- 1 year ago - Samsung Backs Scholarly AI Bot Serving Students and Academics - BNN Bloomberg